Patent US4855026A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3934580A Expired / Lapsed US ⏱️ 0.0 years remaining

Chemically acting intra-uterine device

Assignee: APAMED ANSTALT
•
Filing: 1974-11-11
•
Granted: 1976-01-27
•
Expires: 1994-11-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention is directed to an active intrauterine device comprising a hydrophobic substrate of high mechanical resiliency, wherein the substrate including within the volume thereof inclusions of polymerizied hydrophilic substances grafted on the hydrophobic substrate and cross-linked, and in which water-soluble chemical agents have been stored previously, these agents being adapted to perfuse through the hydrophobic substrate when the latter is placed in an aqueous medium.

Inventors

  • 👤 Rene Cournut

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 23:36
CPC Classifications
A; A61; A61F; A61F6/00; A61F6/06; A61F6/14; A61F6/142; A61F6/148; A61K; A61K9/00; A61K9/0012; A61K9/0034; A61K9/0039; A61M; A61M31/00

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 65 words
An active intra-uterine device comprising a hydrophobic substrate of high mechanical resiliency, wherein said substrate comprises, within the volume thereof, inclusions of polymerized hydrophilic substances grafted on said hydrophobic substrate and cross-linked, in which water-soluble chemical agents have been stored previously, said hydrophobic substrate being porous so that said agents may perfuse through said hydrophobic substrate when the latter is placed in an aqueous medium.
Claim 2
Dependent Claim 65 words
An active intra-uterine device comprising a hydrophobic substrate of high mechanical resiliency, wherein said substrate comprises, within the volume thereof, inclusions of polymerized hydrophilic substances grafted on said hydrophobic substrate and cross-linked, in which water-soluble chemical agents have been stored previously, said hydrophobic substrate being porous so that said agents may perfuse through said hydrophobic substrate when the latter is placed in an aqueous medium.
Claim 3
Dependent Claim 13 words
A device according to claim 1, wherein the hydrophilic inclusions contain contraceptive agents.
Claim 4
Dependent Claim 21 words
A device according to claim 1, wherein the hydrophilic inclusions contain chemical agents selected from the group comprising antibiotics and cortisone.
Claim 5
Dependent Claim 21 words
A device according to claim 1, wherein the hydrophilic inclusions contain substances likely to acclimatize the intra-uterine device in the uterus.
Claim 6
Dependent Claim 44 words
A device according to claim 1, wherein said hydrophobic substrate is made of an organic polymer selected from the thermoplastic group comprising vinyl acetate, polyethylene, polypropylene, polyamides, ethylene-glycol, polyterephtalate, polyvinyl chloride, polyformaldehyde chloride, polycarbonates, ethylene co-polymers, a polyether, a polyurethane, a polyacrylonitrile and polytetrafluoroethylene.
Claim 7
Dependent Claim 19 words
A device according to claim 1, wherein said hydrophobic substrate is an organic co-polymer of vinyl acetate and polyethylene.
Claim 8
Dependent Claim 52 words
A device according to claim 1, wherein said hydrophilic substance forming the inclusions is selected from the group comprising ethylene-glycol acrylate, ethylene-glycol methacrylate, acrylamide, methacrylamide, acrylamide methylol, acrylamide diacetone or an unsaturated acidic product such as malic acid, acrylic acid, methacrylic acid, fumaric acid, itaconic acid or propylene glycol acrylate or methacrylate.
Claim 9
Dependent Claim 26 words
A device according to claim 2, wherein the contraceptive agents contained in said inclusions are selected from the group comprising copper-, zinc-, cobalt-, lead- and cadmium-salts.
Claim 10
Dependent Claim 26 words
A device according to claim 1, wherein said inclusions contain a contraceptive agent selected from the group comprising progestational agents, spermicidal agents and soluble oestrogenic agents.
Claim 11
Dependent Claim 46 words
A device according to claim 1, comprising, within said inclusions, substances for acclimatizing the said intra-uterine device within the uterus, wherein said inclusions contain at least one substance selected from the group comprising analgesics, vitamin K, ε-amino caproic acid, ergotamine, diosmine, iron sulphate, calcium and ergotine.
Claim 12
Dependent Claim 69 words
A device according to claim 1, including a resilient plastic frame endowed with a high resilient memory, onto a portion of which is welded a thin sheet, at least one of the materials forming said sheet and said frame being made of a hydrophobic substances provided with hydrophilic inclusions, the said inclusions being filled with treatment chemical agents and with substances for acclimatizing the intra-uterine device in the uterus.
Claim 13
Dependent Claim 86 words
A device according to claim 1, including a resilient plastic frame endowed with a high resilient memory onto a portion of which are welded two thin sheets which are, in their turn, welded along their peripheries defining an enclosed free space between said thin sheets, at least one of the materials forming the two sheets and the said frame being a hydrophobic substance provided with hydrophilic inclusions, said inclusions being filled with treatment chemical agents and with substances for acclimatizing said intrauterine device within the uterus.
Claim 14
Dependent Claim 33 words
A device according to claim 12, wherein said space defined by said two thin sheets is filled with a solution containing contraceptive agents and substances for acclimatizing said intra-uterine device within the uterus.
Claim 15
Dependent Claim 26 words
A device according to claim 12, wherein said hydrophobic substrate forming the sheet or sheets welded to the plastic frame is made from a square polymer.

References Cited (Backward Citations)

US3633574A Cited
US3659596A Cited
US3845761A Cited
US3786808A Cited
US3785376A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-01-26 1979-07-28 1980-01-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-01-26 1983-07-28 1984-01-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-01-26 1987-07-28 1988-01-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag